%0 Journal Article
%T Response to Single Low-dose 177Lu-DOTA-EB-TATE Treatment in Patients with Advanced Neuroendocrine Neoplasm: A Prospective Pilot Study
%A Fang Li
%A Hao Wang
%A Hui Li
%A Jie Zang
%A Jingjing Zhang
%A Jingnan Wang
%A Orit Jacobson
%A Qingxing Liu
%A Xiaoyuan Chen
%A Yuejuan Cheng
%A Zhaohui Zhu
%J Theranostics
%D 2018
%I Ivyspring International Publisher
%R 10.7150/thno.25919
%X Objective: 177Lu-DOTA-EB-TATE is a theranostic agent based on octreotate that uses an Evans blue structure to bind albumin to improve the pharmacokinetics and pharmacodynamics. This pilot study aims to evaluate the efficacy of a single low-dose treatment using 177Lu-DOTA-EB-TATE in patients with advanced neuroendocrine neoplasm (NEN).
%K 177Lu-DOTA-EB-TATE
%K 68Ga-DOTA-TATE
%K neuroendocrine neoplasm
%K treatment
%K PET/CT
%U http://www.thno.org/v08p3308.htm